Published in Obstet Gynecol on November 01, 2009
What is the Nature of Pelvic Floor Muscle Involvement in Dyspareunia? | NCT04234555
Botulinum toxin for conditions of the female pelvis. Int Urogynecol J (2013) 1.39
Clinical uses of botulinum neurotoxins: current indications, limitations and future developments. Toxins (Basel) (2012) 1.04
Understanding and treating vaginismus: a multimodal approach. Int Urogynecol J (2014) 0.77
Vaginismus Treatment: Clinical Trials Follow Up 241 Patients. Sex Med (2017) 0.75
Revised definitions of women's sexual dysfunction. J Sex Med (2004) 2.03
Vulvodynia: a state-of-the-art consensus on definitions, diagnosis and management. J Reprod Med (2006) 1.66
Secondary provoked vestibulodynia in sexually active women with uncomplicated recurrent urinary tract infections. J Sex Med (2013) 1.45
Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy. Maturitas (2005) 1.37
Hypoactive sexual desire disorder in menopausal women: a survey of Western European women. J Sex Med (2006) 1.08
Sexual function and sexual distress in women with interstitial cystitis: a case-control study. Urology (2007) 1.02
Relationship between hypoactive sexual desire disorder and aging. Fertil Steril (2006) 0.99
A symptomatic approach to understanding women's health experiences: a cross-cultural comparison of women aged 20 to 70 years. Menopause (2007) 0.94
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer. Eur J Cancer (2012) 0.93
A randomized controlled trial of IV immunoglobulin in patients with postpolio syndrome. J Neurol Sci (2013) 0.91
Deficits of temporal discrimination in dystonia are independent from the spatial distance between the loci of tactile stimulation. Mov Disord (2002) 0.89
Weight and height gain after intrathecal baclofen pump implantation in children with spastic tetraparesis. Dev Med Child Neurol (2004) 0.87
Hormone therapy and sleep quality in women around menopause. Menopause (2005) 0.85
Can Lactobacillus fermentum LF10 and Lactobacillus acidophilus LA02 in a slow-release vaginal product be useful for prevention of recurrent vulvovaginal candidiasis?: A clinical study. J Clin Gastroenterol (2014) 0.84
Vincristine-related neuropathy versus acute inflammatory demyelinating polyradiculoneuropathy in children with acute lymphoblastic leukemia. J Child Neurol (2012) 0.84
Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: a randomized, double-blind, placebo-controlled study. J Sex Med (2011) 0.83
Botulinum toxin for the treatment of genital pain syndromes. Gynecol Obstet Invest (2004) 0.82
Risk factors for post-polio syndrome among an Italian population: a case-control study. Neurol Sci (2012) 0.80
Arthralgias, bodily aches and pains and somatic complaints in midlife women: etiology, pathophysiology and differential diagnosis. Expert Rev Neurother (2007) 0.79
Spread of botulinum neurotoxin type a at standard doses is inherent to the successful treatment of spastic equinus foot in cerebral palsy: short-term neurophysiological and clinical study. J Child Neurol (2011) 0.78
Vestibulodynia: synergy between palmitoylethanolamide + transpolydatin and transcutaneous electrical nerve stimulation. J Low Genit Tract Dis (2013) 0.76
Patient scenario: a 53-year-old woman with hypoactive sexual desire disorder. Maturitas (2009) 0.75
Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months. Arch Dermatol (2011) 0.75
Testosterone and libido in surgically and naturally menopausal women. Womens Health (Lond Engl) (2006) 0.75
Coexisting idiopathic cervical dystonia and primary vaginismus : a case report. J Neurol (2008) 0.75
Central nervous system abnormalities in vaginismus. Clin Neurophysiol (2008) 0.75